Stevens-Johnson syndrome associated with bezafibrate.
Sawamura
D
D
Umeki
K
K
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D001629:Bezafibrate / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000175:diagnosis / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology
D000305:Adrenal Cortex Hormones; D000960:Hypolipidemic Agents; D001629:Bezafibrate